FTSE 100 turns positive after soft start, Rentokil gains

The FTSE 100 was in consolidation mode on Wednesday morning after a China-induced rally on Tuesday. However, the bulls took control after lunch and sent the index over 0.3% higher.

The impact of China’s stimulus measures fizzled out on Wednesday morning, although the key beneficiary mining sector was still higher for the week. 

London’s leading index even managed to carve out gains despite weakness in oil heavyweights BP and Shell who slipped back with oil prices.

“Brent Crude remains close to $75 a barrel as supply concerns continue to swirl. Although crude prices remain well below the peak in 2022, when they were nudging $120 a barrel, the intensity of the Israel’s attacks on targets in Lebanon has increased concerns that that the conflict will spread further across the Middle East,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

The stocks leading the rally at midday included Rentokil, Fresnillo, and Croda. Rentokil was the top riser, up 4%, after an activist investor took a board seat following a period of poor performance.

“Pest control outfit Rentokil was not in a strong position to refuse any requests from activist investor Nelson Peltz, so news that a representative from his Trian Fund Management vehicle is joining the board shouldn’t come as a big surprise,” said AJ Bell’s Russ Mould.

“After serving up a doozy of a profit warning earlier this month, Rentokil’s board is hardly in a position to suggest it doesn’t need help or fresh ideas, and it will be interesting to see where Peltz looks to exert pressure. 

“Weaker than expected revenue at Rentokil has been compounded by internal problems around the integration of acquired branches and poor cost control as the company strained to hit sales targets. This state of affairs does not reflect well on the company’s discipline.”

With little economic news on Wednesday, the big story in London is the Rightmove takeover interest from Rupert Murdoch’s REA Group and the third revised bid announced on Wednesday. Like the two prior bids, the third was rejected by Rightmove.

“While there was a shift in the tone of Rightmove’s announcement earlier this week in that it was ‘carefully considering’ REA’s latest proposal, it didn’t take long for the property portal to go back to its dismissive ways,” Russ Mould said.

“REA looks to be running out of patience with Rightmove after it rejected a third takeover proposal, banging the drum even louder that it’s bad form not to properly engage in a conversation. This sets the tone for REA taking a hostile approach, bypassing the board and negotiating directly with shareholders.

“Rightmove’s biggest investors are asset management firms and they will all have a price at which they’d be happy to let their shares go. Names like Kayne Anderson Rudnick, BlackRock and Lindsell Train won’t be emotionally attached to a business like Rightmove in the way a founder or company employee might be. They’re holding Rightmove stock to make money and it’s clear that REA continues to want the business.”

AIM movers: Enteq Technologies funding and Directa Plus tenders delayed

1

Ovoca Bio (LON: OVB) reported a halved loss of €1.2m due to lower overheads. Cash was €2.9m at the end of June 2024 and cash refunds from the Australian government of €650,000 are anticipated.  The share price rebounded 92.6% to 1.3p.

Further contract news from Electric Guitar (LON: ELEG) has boosted the share price 30.8% to 0.85p. It has developed a loyalty app alongside joint venture Marcomms.ai and Little Birdie. This is focused on integrating Open Banking, customer engagement and personalised insights. This follows a campaign win with Singapore-based media network Mediacorp, which is using the Voco engagement platform was used to capture customer data on its website.

Technology companies developer Tekcapital (LON: TEK) increased its NAV from 27 cents/share to 35 cents/share in the six months to June 2024. This is due to rises in the valuation of unquoted portfolio companies and the flotation of Microsalt (LON: SALT). There are plans to float generative AI business GenIP, so that could provide a further boost. The Tekcapital share price rose 10.8% to 7p.

Shield Therapeutics (LON: STX) has revealed phase 3 paediatric study results for ACCRUFeR, its iron deficiency anaemia treatment, that show highly clinically relevant effectiveness. This will support filings with the FDA and the European authorities for children older than one month. The FDA filing should be in the first quarter of 2025. The share price increased 9.72% to 3.95p.

FALLERS

Energy services supplier Enteq Technologies (LON: NTQ) has raised £1.5m from a placing and subscription at 5p/share. A retail offer could raise up to £500,000 and it closes on 30 September. The cash will help to finance the commercial launch of the SABER (Steer-at-Bit Enteq Rotary) tool. Testing with the first customer is ongoing. The fleet of SABER tools will be raised to ten. The share price slumped 41.7% to 5.25p.

Graphene technology developer Directa Plus (LON: DCTA) is taking a cautious approach to the environmental remediation tenders that it has been expecting to be awarded. These have been removed from forecasts and full year revenues are estimated at €7.3m, down from €10.5m, with a loss of €5.1m. The interim revenues declined 27% to €3.45m, although this was partly offset by the concentration on higher margin business. If Directa Plus wins one of the tenders, then revenues could rise significantly over the next year. There should still be net cash of €5.2m at the end of 2024, so Directa Plus can wait for the tenders to come through. The share price dipped 28.1% to 11.5p.

Anglesey Mining (LON: AYM) has raised £220,000 at 1p/share. This will finance development work at Parys Mountain and further assessment of the Grangesberg iron ore mine. The share price fell 22.2% to 1.05p.

Data analytics technology developer Cirata (LON: CRTA) says finance director Ijoma Maluza will step down at the end of 2024. He was involved in the turnaround of the company. Ricardo Moura will join the board at the end of September and take on the role of interim finance director. The share price declined 20.3% to 23.025p.

itim Group – ‘Retail Engineers’ Report Positive Interims And Strong Cash Generation, Broker Ups Estimates 

Yesterday’s Interim Results from the itim Group (LON:ITIM) were better than expected. 

The group, which is a SaaS based technology company that enables store-based retailers to optimise their businesses to improve their efficiency, effectiveness and financial performance, reported revenues up 19% in the first half year to end-June. 

In reaction the group’s shares put on a useful 18% advance in price, to 41.50p, valuing it at only £12.95m. 

The Business 

Established in 1993 by its founder, and current Chief Executive Officer, Ali Athar, was initially formed as a consulting business, helping retailers to effect operational improvement.  

From 1999 the company began to expand into the provision of proprietary software solutions and by 2004 it was focused exclusively on digital technology.  

Over the years it has grown both organically and through a series of acquisitions of small, legacy retail software systems and associated applications, which the group has redeveloped to create a fully integrated end-to-end ‘omnichannel’ platform. 

That platform enables retailers to adopt an engaging customer-centric approach to shopping in-store, online and on mobile.  

Its retail software solutions support multi-channel sales and service, enterprise order management, price and stock optimisation, and supplier management. 

Today the company works with over 80 retailers across 11 countries, a small range of its clients includes: Whitbread, Majestic Wine, Argos, The Entertainer, John Lewis, Sainsbury’s, The Fragrance Shop, Costa Coffee, JC Penney, Walmart, McDonalds, Quiz, Co-Op, Waitrose, WH Smith, and Travis Perkins. 

It provides ‘omnichannel’ retailers with a ‘Unified Retail’ platform designed around the customer, that leads to increased sales and profitability. 

The Equity 

There are some 31.2m shares in issue. 

Larger holders include the Athar family (38.40%), Lewis family (18.07%), Robert Frosell, Dir (7.64%), Herald Investment Management (6.37%), Curtis family (4.12%), Ian Hayes, Dir (2.72%), Michael Jackson, Dir (1.76%), Sandra da Costa Ribeiro, Dir (0.87%) and Justin King (0.74%). 

Analyst Views 

John Cummins and Charlie Cullen yesterday upped their estimates for the current year to end-December to look for revenues of £17.1m (£16.1m), and an adjusted pre-tax loss of £0.7m (£1.1m loss).  

The analysts were previously expecting a £1.0m loss this year, so the small improvement is noteworthy. 

They were also anticipating that the company would end this year with £0.5m cash in the bank, but now they have adjusted their figures to seek a useful £2.1m cash at year-end. 

For 2025 they foresee £18.0m sales, and a turn around into £0.4m profits, worth 1.9p per share in earnings per share. 

They note that with an encouraging pipeline of business leading into next year, they view the company as very well placed to continue to deliver into FY2025 and see substantial room for upside as new contracts are secured.   

The analysts have previously stated that they consider that this group’s shares were trading on an undemanding rating compared to their ‘fair value’ of 55p a share. 

In My View 

Capitalised at only £12.95m, even with its shares 18% better yesterday at 41.50p, it will have £2.1m cash in the bank at the year-end. 

I can see the broker’s analyst price estimates as being easily achieved in due course. 

Tekcapital hints at Guident IPO as NAV surges higher in first half

Tekcapital shares were higher in early trading on Wednesday after the technology group announced a 46% jump in NAV and hinted at the IPO of portfolio company Guident.

“We are excited to report significant progress across our portfolio companies. This has resulted in the growth of our Net Assets during the period by ~ 46% reaching US$69.8m with an NAV per share of US$0.35,” said Dr. Clifford M. Gross, Tekcapital Chairman.

“Our first half performance reflects strong commercial progress of the portfolio companies during the period. I’m delighted that each portfolio company has grown its respective revenues this year, validating our investment case for each company and the Tekcapital investment process.”

Microsalt, the low-sodium technology company, accounted for a large proportion of the NAV gains after it listed in London in February this year. The company has agreements with one of the world’s largest snack foods businesses to supply low-sodium salt, as well as extensive retail distribution channels.

Following MicroSalt’s successful listing earlier this year, Tekcapital is moving forward with its strategy of creating shareholder value through achieving portfolio company liquidity events by launching AI analytics company GenIP.

“As part of our strategy to create value from innovative technologies, we launched GenIP this summer. We feel its forthcoming IPO will provide UK-focused investors with a unique opportunity to secure exposure to the fast-growing Generative AI analytics market,” Gross said.

The surprise proposed GenIP IPO will add around £5m of liquid NAV to the portfolio.

Guident IPO

Investors who see Guident as the jewel in Tekcapital’s crown will be delighted to see the Tekcapital group Chairman hint at a listing after noting revenue-generating progress for the autonomous vehicle safety company.

“Guident has made material progress in commercialising its autonomous vehicle safety solutions, and revenue generation has increased accordingly,” Gross said.

“We believe improving market conditions and Guident’s commercial advancements are creating the ideal opportunity for Tekcapital to crystalise the balance sheet value held in the company while providing a greater pool of investors the chance to join us in the next phase of Guident’s scale-up. As previously announced, Guident is seeking a private investment round and, once consummated, should have the investor support for a range of possible future funding opportunities, including an initial public offering.”

Guident has plenty of space for a higher valuation on listing given the size of the addressable market and Guident’s SaaS model, which provides recurring revenues.

Portfolio management

In this update, Tekcapital alluded to taking a measured approach to managing its portfolio. Although nearly all of Tekcapital’s technology companies are now listed, the company clearly still has a desire to capture new opportunities.

Interestingly for investors, the Tekcapital board has also displayed flexibility in their approach to creating value for shareholders, which is likely to expedite returns. The company has previously opted to found companies and provide seed capital directly into them. The approach to GenIP is different because the first major funding round is the upcoming IPO.

This does two things. First, it allows investors to gain exposure to the company in the early stages when the company grows rapidly. Second, it reduces reliance on Tekcapital for growth capital.

Dr Clifford Gross said that the company is at ‘an inflection point’ and shares have reacted accordingly on Wednesday.

AIM movers: Ondine Biomedical raises money at a premium and Itim breaks even in the first half

0

Ondine Biomedical Inc (LON: OBI) has raised £2.8m at 12.5p/share, although the transaction is not expected to be completed until early November. This follows a partnership with Sweden-based Molnlycke Health Care that will take the Steriwave nasal antimicrobial treatment in the European and Middle East markets. The UK is the initial focus. The addressable market is $300m. The share price improved 26.7% to 7.125p.

Retail software developer Itim Group (LON: ITIM) managed to breakeven in the first half of 2024 on a 19% increase in revenues to £8.8m. Net cash is £3m. Zeus upgraded its 2024 expectations to a loss of £700,000, down from £1m. Net cash should be £2.1m at the end of 2024. The share price rose 18.6% to 41.5p.

Mortgage Advice Bureau (LON: MAB1) improved interim revenues by 5% to £123.9m, while underlying pre-tax profit was two-fifths ahead to £12.3m. The interim dividend is maintained at 13.4p/share. The market share for new mortgage lending edged up from 8.2%. Revenue per adviser was 9% higher. After a weak second quarter there are signs of demand gradually building. New case numbers are 11% ahead in July and August. The share price increased 6.43% to 579p.

Investment company Seed Innovations (LON: SEED) says it is optimistic about its investment portfolio and it had £3.5m in cash at the end of August. Cash alone covers the market capitalisation, while estimated NAV is £10.8m. The share price is 10.3% higher at 64p.

FALLERS

Corcel (LON: CRCL) says 90%-owned Atlas Petroleum Exploration Worldwide has authorisation for the assignment of an additional 20% interest in operated block KON-16, onshore Angola. Apex will have a 55% interest. Corcel has raised £1.22m at 0.1p/share. The share price slipped 21.2% to 0.1025p.

Clontarf Energy (LON: CLON) has raised £450,000 at 0.045p/share. The cash will be invested in the Bolivian lithium interests. The share price fell 12.2% to 0.0505p.

Scancell (LON: SCLP) reported a pre-tax loss of £9.1m in the year to April 2024 following an increase in research and development spending. Net cash is £14.8m and that could fall to £4.7m by the end of April 2025. Scancell is expected to release data on three different cancer vaccines in the next nine months. The share price declined 6.67% to 14p.

Manx Financial (LON: MFX) reported interims showing a 16% increase in pre-tax profit to £3.5m. The net loan book grew and that offset lower net interest income. The board believes that the second half will be less positive than the first half. The share price dipped 3.13% to 15.5p.

FTSE 100 jumps after additional Chinese stimulus

Chinese stimulus helped propel the FTSE 100 higher on Tuesday as the world’s second-largest economy stepped up its efforts to support the economy.

China has taken a different approach to the slowing economy over the past year by holding back from major stimulus and choosing to let events play out – much to the displeasure of investors who had become accustomed to China acting at the first sign of weakness.

However, China’s stuttering growth has proved too much for Beijing, which again moved to stimulate the economy overnight, sending Asian stocks soaring.

“China has been searching for solutions to its economic growth challenge for some time, and stimulus measures haven’t really worked. It’s gone from being a trailblazer with supersonic economic expansion to a country whose batteries were close to running out of energy. It’s now gone all-in with its bet on getting the economy back into top gear and that’s driven the mother of all rallies on the Chinese stock market,” said Russ Mould, investment director at AJ Bell.

China chose to focus on the much-loved housing market for the latest major stimulus to help the struggling industry after years of slow growth and debt troubles.

“The People’s Bank of China has delved into its bag of tricks to try to get growth back to the 5% target, including cuts to interest rates, mortgage rates, and downpayments for house buyers,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

The focus on housing plays straight into the Chinese wealth effect and the historical investment case for the country as a consumer of natural resources.

“The Shanghai SSE index jumped 4.15% while the Hang Seng soared by 4%, indicating that investors are pleased with plans to lower borrowing costs and allow banks to increase their lending. That had a direct read-across to the FTSE 100 and its army of commodity producers who should benefit from greater economic activity in China and for London-listed companies which do business with consumers in the country including Burberry and Prudential,” Russ Mould said.

The miners are almost always the biggest beneficiaries of Chinese stimulus, and on Tuesday, Antofagasta, Rio Tinto, and Anglo American were all among the top gainers. 

Smiths Group was the top faller, down 7%, after releasing lacklustre full year results.

CleanTech Lithium – ASX Dual-Listing Process Slowed Down By ‘Procedural Matters’ Sees Shares Gyrate 

Plans are currently being delayed by ‘procedural matters’ in this group’s application for a listing on the Australian Securities Exchange. 

On Tuesday 13th August the hopes were that CleanTech Lithium (LON:CTL) had submitted its Prospectus for a dual-listing on the ASX. 

It also inferred that it was hoping to raise up to A$20m in the process. 

Management Comment 

At that time Chairman and Interim CEO Steve Kesler stated that: 

“CleanTech Lithium is positioning itself to become a leading supplier of battery-grade lithium to the growing EV and energy storage market to support the global energy transition. 

We’re excited of the prospect to join the ASX which is home to many of the world’s leading lithium companies. 

In addition to our existing AIM listing, the dual-listing in Australia will provide us with access to a broader collection of security holders and stakeholders who have a deep understanding of the lithium industry and its importance in supporting the world’s ambitions for net-zero.  

We are looking forward to introducing CTL to the Australian market, providing Australian investors the opportunity to invest in an emerging producer of battery grade lithium from a country with an established lithium industry, an FTA with the USA and a preferential trade agreement with the EU. 

Our two core projects host, in aggregate, total resources of more than 2.7 million tonnes of LCE and we are advancing the use of DLE technology, which features much higher recovery rates and less environmental impact compared to conventional forms of lithium extraction.  

We are also aiming to be powered by renewable energy once in production, utilising Chile’s excellent renewable energy resources including in the region of our projects. 

Harnessing DLE and renewable energy positions CTL to be a leader in a more efficient method of producing lithium in Chile, and we believe this will give us an advantage in supplying a premium lithium product to the market.” 

The company declared that the proceeds of the proposed Fundraising could be applied towards the development of the company’s suite of projects in Chile, primarily the completion of the Pre-Feasibility Study at the Laguna Verde Project and ongoing operations at the DLE pilot plant, which is producing battery-grade lithium carbonate.  

CTL’s projects are centred in an area of northern Chile dubbed the ‘lithium triangle’ which is shared with Argentina and Bolivia.  

CTL aims to become a leading producer and supplier of ‘green’ battery-grade lithium to the Electric Vehicle and Energy Storage market by utilising advanced environmentally-sensitive processing technology powered by renewable energy. 

Submission Of Replacement Prospectus 

On Tuesday 27th August the group announced that it had needed to issue a Replacement Prospectus to the ASX clarifying the scalability and global usage of Direct Lithium Extraction and the company’s reliance on renewable energy and potential exposure to fossil fuels.  

The amended copy now also contains additional information on the Chilean national electricity grid’s existing high renewable energy mix.  

It noted that it plans, where possible, to include renewable energy sources to power operations in line with its objective of promoting sustainable lithium production. 

At that time the company stated that it did not anticipate that the lodgement of the Replacement Prospectus would impact the timing of its admission to ASX and declared that admission is expected to occur on or around 24th September. 

Offer Period Extended 

On Monday 9th September the company noted the delay and reactively decided to extend the Offer Period for its fundraising from 9th September to 23rd September. 

It stated that it will provide a further update once it has received confirmation of the proposed ASX Admission and commencement of trading dates.  

Update On Its ASX Listing 

Last Friday 20th September the company announced that it had been informed by representatives of the Australian Securities Exchange that due to procedural matters the approval process of the company’s listing on ASX will be extended. 

CleanTech Lithium informed investors that it is working with its lawyers in Australia, its other advisers and ASX to address the matters expeditiously and will provide the market with a further update when greater clarity has been obtained on the revised expected timetable. 

In My View 

This £23m capitalised group’s shares, which hit 94p in February last year and were down to just 10.50p in April this year, before rapidly picking up to 25.30p in late July, then drifted back to 14p just over a month ago. 

Despite the ‘procedural delays’ they are now trading at around the 15p level. 

I hope that the company can get its ASX listing speeded up, thereby enabling the required funding to complete. 

Getting that out of the way will allow mining sector punters to react rapidly to any items of good corporate news that are sure to follow. 

Should you buy an S&P 500 ETF now?

Should I buy an S&P 500 ETF at current levels? There’s no two ways about it, for many investors, buying the S&P 500 index is probably the best thing they could do if they’d like to get exposure to the stock market.

The numbers are compelling. The S&P 500 has outperformed most active managers by some margin over the past decade. 

However, while this fact is often touted by ETF proponents, it doesn’t take into consideration that private investors can be a lot more nimble than your average fund manager, apply a degree of trading to their portfolios, boosting returns.

That is, of course, if they have the experience to do so. Those who don’t have a reasonable level of experience in the stock market are probably better suited to sticking to the broader equities indices.

Investors in the S&P 500 index will gain exposure to the world’s largest companies. Household names such as Apple, Microsoft, Nvidia, and Amazon make up a large proportion of the index and, therefore, your investment when you buy an S&P 500 index ETF.

These companies and the S&P 500 have been a safe bet and will likely remain so for the foreseeable future. 

There is one technique that savers and investors should be aware of to help smooth out the inevitable bumps in the road when investing in stocks. 

That’s dollar cost averaging. Or pound cost averaging, depending on which side of the Atlantic you’re on.

The answer to our question of whether you should buy an S&P 500 ETF at current levels is probably yes. But it will also be yes at the same time next month, and the month after that, and, yes, the month after that.

By drip-feeding your cash into the S&P 500 on a regular basis, you even out your investment and soften any bouts of volatility. They even become an opportunity and can boost your long-term returns.

Who knows if the S&P 500 will be 5% higher or lower next month? With dollar cost averaging, it doesn’t matter; you buy anyway. It builds your investment and smooths out the entry points.

Raspberry Pi EBITDA soars as supply recovers

Fresh after London’s largest technology IPO of 2024, the computing and technology company announced a solid set of first half results on Tuesday. Raspberry Pi raised $179m in June this year.

Despite marginally lower volumes than the comparative period, Raspberry Pi’s overall performance was better than expected during the period. 

EBITDA was 55% higher in H1 2024 than in H1 2023 due to issues with supply in the first half of last year which made this year’s number look that much better.

Investors will also be encouraged to hear that the company sees higher volumes in the second half. 

“The IPO was the watershed moment of the first half, with Admission to trading just two weeks before the period end,” said Eben Upton, CEO of Raspberry Pi.

“In continued pleasing trading in the first half, we saw strong uptake of our latest flagship SBC, Raspberry Pi5, the launch of the Raspberry Pi AI Kit, and the successful ramp to production of RP2350, our second-generation microcontroller platform. The higher than usual customer and channel inventory levels which were evident at the time of the IPO have continued to unwind, and there is a growing sense that this will have concluded by the year end.

“We have an extraordinary team, a world class product set backed up by an exciting future roadmap, and a loyal and engaged customer base that we can continue to grow. In the second half, we have further planned product releases and a number of initiatives to further expand our engagement within our Industrial and Embedded market”.

Antofagasta shares: FTSE 100 mining pick for a recovery in copper prices and the green transition

Antofagasta shares are supported by long-term structural economic expansion and the demand for copper from the clean energy transition.

After touching highs above $10,000 per tonne earlier this year, copper prices have gently eased amid concerns about Chinese growth. However, the Federal Reserve’s decision to start cutting interest rates has sparked a rally in the copper, which touched two-month highs last week. 

Copper’s high correlation with the underlying growth environment has earned the metal the title ‘Dr Copper’, as a rise in the price of metal is usually caused by improving sentiment or economic expansion.

It remains to be seen whether the recent rally in copper is just a result of improving sentiment after the Fed cuts interest rates or is a predictor of future economic buoyancy. Indeed, the shift in copper’s narrative to US interest rates away from Chinese growth will likely be short-lived.

That said, if we see any signs of positivity from China in the coming months, copper prices have plenty of space to rally.

In addition to immediate macroeconomic considerations for the price of copper, the metal is set to benefit from long-term structural demand from the green energy transition. For all the furore around lithium, cobalt, and uranium, copper is the essential metal at the heart of most green energy technologies, including electric vehicles and power generation.

Investors seeking exposure to further recovery in the price of copper or would like to position for the green transition without buying futures or trading another form of derivative should look no further than Antofagasta.

FTSE 100-listed Antofagasta is the ultimate play on copper prices for UK-focused equity investors. The company’s resource base is around 21 billion tonnes, making it one of the world’s leading copper miners in terms of resources.

Focused on Chilean copper assets, Antofagasta’s strength lie in extensive production operations and the supportive environment for copper prices.

Antofagasta invested in mining operations at a time when capital costs were much lower. This provides investors with the attractive advantage of an upside in copper prices without the CAPEX required to bring mines online.

It has become hugely expensive to construct new mines, leading to a dearth of new mines coming on line. It’s one thing for early-stage companies to identify economically viable resources; securing the funds to extract them is something entirely different, especially at the scale at which Antofagasta is operating.

Antofagasta produced 284,000 tonnes of copper in the six months to the end of June 2024. Although this was slightly lower than in the same period last year, group revenues rose 2% due to a higher comparative copper price.

The company expects to spend $2.7bn in capital expenditure for the full year. A large proportion of this will be allocated to improving facilities to increase copper production.

Antofagasta has plentiful resources in place, and its growth strategy is to increase the pace at which it is monetised. Very few miners have the mineral or capital resources to achieve the levels of production Anto is targeting, giving it a huge competitive advantage.

Investors should also note the company’s willingness to return cash to shareholders. Antofagasta pays out 35% of underlying earnings per share. This policy means payouts can be volatile, but it leaves plenty of opportunity for substantial payouts on periods of good performance. 

In conclusion, the stock offers robust chances of both capital growth and income, and with shares below 2,000p, it should be on the watch list of any natural resources fan.